Administration of raloxifene hydrochloride nanosuspensions partially attenuates bone loss in ovariectomized mice

Postmenopausal osteoporosis is a systemic skeletal disease of fragility fractures due to the loss of the mass and the deterioration of the microarchitecture of bone. This study aimed to assess the effects of raloxifene hydrochloride nanosuspensions (RLX-NSps) on ovariectomized (OVX)-induced osteopor...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Meihua, Qi, Xiaoyu, Bi, Dongdong, Li, Yijing, Guo, Yifei, Wang, Xiangtao, Feng, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081861/
https://www.ncbi.nlm.nih.gov/pubmed/35540259
http://dx.doi.org/10.1039/c8ra02535e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081861/
https://www.ncbi.nlm.nih.gov/pubmed/35540259
http://dx.doi.org/10.1039/c8ra02535e

Ejemplares similares